USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11796
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGalașanu, Anghelina
dc.date.accessioned2020-09-29T14:43:11Z
dc.date.available2020-09-29T14:43:11Z
dc.date.issued2020
dc.identifier.citationGALAȘANU, Anghelina. Paracetamol - benefits and damages. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 282-283.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11796
dc.descriptionDepartament of Pharmacology and Clinical Pharmacology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. Paracetamol and the combined drugs, which belong to the OTC list that are released without a prescription, are most commonly used in the symptomatic treatment or selftreatment of acute respiratory infections. The diversity of trade names often misleads patients who resort to their administration without consulting a doctor. For these reasons, there is an increase in the incidence of acute intoxication and fatal adverse reactions (fulminant hepatic necrosis, etc.). Aim of the study. The aim of the study consisted in analyzing the presence on the pharmaceutical market of mono- and combined drugs containing paracetamol and estimating possible risk of side effects in self-treatment with them. Materials and methods. Based on the study of the State Drug Nomenclature, were selected drugs containing paracetamol with analysis of single dose and combination diversity. Results. In the Republic of Moldova there are 95 mono- or combined drugs containing paracetamol (acetaminophen), including producers from: Moldova - 22, Romania - 20, Ukraine 13, Belarus - 12, Turcia - 5, Russia - 5, Slovenia - 6, Georgia - 4, India - 4, Bosnia and Herzegovina - 2, United Kingdom -1, Germany - 1. The presence of single-dose mono drugs containing paracetamol of 50-250 mg for children and 500-600 mg for adults was found. There is a wide range of combined drugs including: paracetamol + decongestant adrenomimetics (phenylephrine, pseudoephedrine), paracetamol + H1-antihistamines (pheniramine, chlorophenamine), paracetamol + adrenomimetics + H1-anehistamine +, paracetamol + opacimetamine ), paracetamol + H1-anihistamines + opioid analgesics (codeine, promethazine), paracetamol + non-inflammatory anti-inflammatory drugs (propifenazone), paracetamol + antitussive opioid analgesics (codeine, dextromethorphan), which in some cases may have caffeine and / or ascorbic acid added. In accordance with the recommendations of the European Medicines Association the dose of paracetamol in adults for 24 hours is 3.2 g, and in the case of people with pre-existing hepatitis and those who suffer from alcohol abuse, of 2g / 24 hours. The presence of the H1-antihistamine component can result in diminished attention with tragic consequences for drivers, people who do machinery work, as well as the development of dry mucous membranes, including the tracheo-bronchial mucosa, which can enhance the dry cough and decrease the bronchial drainage creating the feeling of ineffectiveness of said drugs. The effect of improved breathing, through the decongestant adrenomimetics, is of short duration (1-2 hours), especially in the first 24-48 hours, which stimulates the more frequent use of drugs with systemic effects, including increased blood pressure, palpitations, tremor. Conclusions. The number and variety of drug combinations of paracetamol impose caution for their use, in order to avoid overdose and the possibility of developing hepatotoxicity.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectparacetamolen_US
dc.subjecthepatotoxicityen_US
dc.titleParacetamol - benefits and damagesen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
Galasanu_Anghelina.pdf444.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback